Conrad M Swartz

Author:

Conrad Swartz

ISBN #:

0521878225

US Patent:

6365618, Apr 2, 2002

Filed:

Dec 13, 2000

Appl. No.:

09/737290

Inventors:

Conrad M. Swartz - Springfield IL 62707

International Classification:

A61K 3140

US Classification:

514411

Abstract:

The compound carvedilol has the chemical formula: Ã-1-(carbazol-4-yloxy)-3-[[2-(o-methyoxyphenoxy)ethyl]amino]-2-propanol. It exists in the form of optical isomers R- and S-carvedilol, and as mixtures of these isomers. It, or one of its optical isomers, is administered, preferably orally, several times per day in tablets of 3-25 mg for the treatment, prevention and clinical arrest of movement disorders associated with medications which block dopamine receptors, including many antipsychotic and antiemetic medications. Such movement disorders include tardive dyskinesia, tardive dystonia, and tardive akathisia. The compound carvedilol is also administered to improve the treatment of mental disorders in which dopamine-blocking medications are used, such as manic episodes, major depressive episodes, and psychoses such as schizophrenia and schizoaffective disorder.

US Patent:

20080188905, Aug 7, 2008

Filed:

Feb 2, 2007

Appl. No.:

11/670589

Inventors:

Conrad M. Swartz - Springfield IL, US

Assignee:

SOMATICS LLC - Lake Bluff IL

International Classification:

A61N 1/36

US Classification:

607 45

Abstract:

A method of treating a patient includes administering an electroconvulsive therapy (ECT) stimulus to the patient. The current is greater than about 0.9 ampere or 1.0 ampere, or is between about 1.0 and about 2 amperes. The energy delivered is about 100 Joules or less across an impedance of 200 ohms. The stimulus may have a pulsewidth between about 0.5 and about 2.0 msec and/or a frequency in the range of about 10 to about 180 Hz, or the stimulus may have a pulsewidth between about 0.2 and about 0.499 msec and/or a frequency in the range of about 15 to about 300 Hz. An apparatus for ECT comprises a generator adapted to deliver such an electroconvulsive therapy stimulus to a patient. A method of calculating ECT dose comprises multiplying a charge to be delivered by the current (or voltage) to an exponential power between 2 and 4.

US Patent:

58715177, Feb 16, 1999

Filed:

Jan 15, 1997

Appl. No.:

8/784128

Inventors:

Richard Stephen Abrams - Chicago IL
Conrad Melton Swartz - Johnson City TN

Assignee:

Somatics, Inc. - Lake Bluff IL

International Classification:

A61N 132
A61N 136

US Classification:

607 45

Abstract:

In medical convulsive therapy (CV), comprising electroconvulsive therapy (ECT) and magnetoconvulsive therapy (MCT), a computer system is used to analyze the effectiveness of the treatment. In one embodiment the effectiveness is determined by measuring the physiological effects on the heart (ECG) muscles (EMG) and brain (EEG).

US Patent:

62003313, Mar 13, 2001

Filed:

Aug 23, 1999

Appl. No.:

9/378817

Inventors:

Conrad Melton Swartz - Richmond Heights MO
Richard Stephen Abrams - Chicago IL

Assignee:

Somatics, Inc. - Lake Bluff IL

International Classification:

A61N 100

US Classification:

607 1

Abstract:

A free-standing device for the testing of ECT (electroconvulsive therapy) instruments, and for training doctors in using such instruments, includes circuits to generate electrical wave forms which simulate the EEG (electroencephalograph) detectable brain waves, EMG (electromyograph) muscle activity and heart beats of a patient undergoing ECT. In one embodiment the ECT output leads of the ECT instrument are plugged into the device, the training doctor selects the ECT current and the device generates response EEG and EMG waveforms. It also measures the current and displays its measurement as a test of the accuracy of the stimulus selection controls of the ECT instrument.

US Patent:

57697787, Jun 23, 1998

Filed:

Jul 7, 1997

Appl. No.:

8/888494

Inventors:

Richard S. Abrams - Chicago IL
Conrad M. Swartz - Johnson City TN

Assignee:

Somatics, Inc. - Lake Bluff IL

International Classification:

A61N 100

US Classification:

600 14

Abstract:

A medical device includes a magnetic stimulator having a magnetic induction coil which is placed next to the scalp of a patient. A pulse train of high energy electrical waves is flowed through the induction coil to produce a sufficiently strong magnetic field to generate currents in the patient's brain for the therapy of psychiatric illnesses. These currents induced in the brain are below the minimum needed to induce a convulsive brain seizure. The device includes an ECG (electrocardiograph) to monitor the electrical activity of the patient's heart and an EEG (electroencephalograph) to monitor the patient's electrical brain waves.

US Patent:

62183958, Apr 17, 2001

Filed:

Aug 2, 1999

Appl. No.:

9/366130

Inventors:

Conrad Melton Swartz - Richmond Heights MO

International Classification:

A61K 4506
A61K 31135

US Classification:

51425215

Abstract:

A combination of medicines are administered daily for the relief of the symptoms of an Anxiety Disorder or an Adjustment Disorder With Anxiety. The combination comprises a centrally-acting beta-blocker which passes the brain blood barrier, preferably the beta-blocker betaxolol, and a serotonin-enhancer, for example, the serotonin agonist buspirone or the serotonin reuptake inhibitor sertraline.

US Patent:

61170666, Sep 12, 2000

Filed:

Sep 23, 1998

Appl. No.:

9/159045

Inventors:

Richard Stephen Abrams - Chicago IL
Conrad Melton Swartz - Richmond Heights MO

Assignee:

Somatics, Inc. - Lake Bluff IL

International Classification:

A61N 100

US Classification:

600 14

Abstract:

In non-convulsive magnetic stimulation therapy a patient is treated with magnetic pulses from a coil placed proximate the patient's head as a treatment of certain neurologic and psychiatric disorders. A set of EEG (electroencephalograph) electrodes on the patient's scalp are switched on during pauses in the electrical pulse train to the coil. If epilepsy-like brain wave spikes and/or sharp waves are detected by the EEG, a warning is given, treatment is halted and an anti-convulsive medicine may be administered.

US Patent:

60390468, Mar 21, 2000

Filed:

Jan 12, 1999

Appl. No.:

9/290102

Inventors:

Conrad Melton Swartz - Richmond Heights MO
Richard Stephen Abrams - Chicago IL

Assignee:

Somatics, Inc. - Lake Bluff IL

International Classification:

A61C 514

US Classification:

128859

Abstract:

An oral protector, especially for use by patients during electroconvulsive therapy (ECT) consists of a flat unitary member which is preferably stamped from a flat sheet of material. The protector is elastic and formed of a closed-cell material, such as polyurethane plastic resin or artificial rubber. It has an elongated, generally elliptical shaped central opening which acts as an air passage.